MedTrace Logo

Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

NCT00800423 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2008-12-02

No results posted yet for this study

Summary

Most patients undergoing cataract surgery suffer from corneal edema after the surgery.

Brimonidine drops are a well known and safe Anti-glaucoma medication. the investigators have made several clinical observations that patients receiving Brimonidine drops had a faster resolution of their corneal edema even if they had normal intra-ocular pressure.

The investigators believe that administering topical Brimonidine to patients with significant post operative corneal edema will hasten the resolution of their corneal edema.

Conditions

  • Corneal Edema
  • Visual Acuity

Interventions

DRUG

Brimonidine Tartrate 0.2%

Brimonidine Tartrate 0.2% drops 1 drop twice a day for 1 month in the operated eye

DRUG

Timolol maleate 0.5%

timolol maleate 0.5% drops 1 drop twice a day for 1 month in the operated eye

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Anat Robinson, MD · Rabin medical center, Clalit health services , Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00800423 on ClinicalTrials.gov